{"doi":"10.1002/cncr.35834","title":"Top advances of the year: Acute myeloid leukemia","abstract":"This article highlights key advances in the treatment of acute myeloid leukemia, specifically menin inhibitors for relapsed disease and retinoic acid/arsenic‐based therapy for high‐risk acute promyelocytic leukemia. Validation of mutational profiles and measurable residual disease methodology as key predictors of treatment outcomes support a personalized, precision‐based treatment approach for acute myeloid leukemia in the future.","journal":"Cancer","year":2025,"id":530603,"datarank":0.0,"base_score":0.0,"endowment":0.0,"self_citation_contribution":0.0,"citation_network_contribution":0.0,"self_endowment_contribution":0.0,"citer_contribution":0.0,"corpus_percentile":null,"corpus_rank":null,"citation_count":5,"citer_count":0,"citers_with_citation_signal":0,"citers_with_endowment":0,"datacite_reuse_total":0,"is_dataset":false,"is_dataset_confidence":0.9537,"is_data_producer":false,"deposit_databanks":null,"is_oa":true,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":"2025-01-01","fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":284267,"name":"Eunice S. Wang","orcid":"0000-0002-8644-0968","position":1,"is_corresponding":false},{"id":1379632,"name":"Rahul Thakur","orcid":"0000-0003-1740-5939","position":0,"is_corresponding":true}],"reference_count":32,"raw_metadata":null,"created_at":"2026-07-19T02:51:05.836974Z","pmid":"40193231","pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}